💜 Thanksgiving Food Drive for Shelter Pets Help Us Feed 1 Million Shelter Pets!
Scientists Examine the Connection Between Microplastics and Colorectal Cancer
Guest Contributor
Microplastics and nanoplastics have shifted from a vague environmental worry to a very personal question: are these tiny particles that now permeate food, water, and air influencing the risk of colorectal cancer? A recent scientific review takes a close look at the emerging evidence on the link between microplastics and colorectal cancer tumorigenesis, and the picture that emerges is both concerning and still incomplete.
Microplastics are plastic fragments between 1 and 5000 micrometers in size, while nanoplastics range from 1 to 1000 nanometers. They can be manufactured deliberately, for example for cosmetics or medical applications, or they can form when larger plastic items break down under sunlight, friction, or chemical weathering. The review explains that humans are exposed through inhalation, skin contact, and especially through ingestion, which is where colorectal cancer risk becomes relevant.
Diet is a major route of exposure. The authors describe how microplastics have been detected in seafood, in foods contaminated through plastic packaging, and even in fruits and vegetables grown in polluted soil. Studies also show that people excrete a variety of microplastics in their stool. This steady stream of particles passing along the intestinal lining has raised understandable questions about their impact on gut health, inflammatory bowel disease, and colorectal cancer.

The review focused specifically on studies connecting ingested microplastics and nanoplastics with colorectal cancer tumorigenesis. Using Ovid MEDLINE and PubMed, the authors searched for work that combined colorectal neoplasm terms with microplastic terms, then applied strict criteria to include only studies that assessed tumor development or tumor-related pathways in colon cells. Out of 41 initial papers, 14 met the inclusion criteria for detailed analysis.
These 14 studies fell into three broad groups: human tissue and fecal studies, mouse models, and in vitro cell culture work using colorectal cancer cell lines such as Caco-2, HT29, HCT116, LoVo, and SW480. Across these different approaches, several themes emerged, including the presence of microplastics in human colorectal tumors, higher microplastic loads in the feces of colorectal cancer patients, increased tumor burden in mice exposed to microplastics, and consistent signs of oxidative stress and DNA damage in exposed cells.
On the human side, several small cross-sectional studies detected microplastics or nanoplastics in nearly all colorectal tumor samples examined. Most of these studies involved 10 to 25 patients, primarily from China and Malaysia. One study compared colorectal cancer samples from the United States collected in the 1990s with samples from Malaysia collected in the 2020s, finding polyethylene, polypropylene, polyamide, and polycarbonate in all cases, and polyethylene terephthalate only in the more recent Malaysian samples. Another study reported that higher levels of certain polymers in colon tissue correlated with elevated cancer biomarkers such as CEA and CA19-9.
The types of polymers detected in tumors varied by study and region. Some work from Tianjin highlighted polyvinyl chloride and polyamide, while other research found polypropylene, polyethylene, polyamide, and polyethylene terephthalate to be most common. However, there is an important nuance. At least one study that compared tumor tissue with adjacent healthy colon tissue did not find a clear difference in total particle counts. Another investigation reported that microplastics were present both in tumoral tissue and in healthy colon samples from people undergoing colectomy for reasons other than cancer. This suggests that the simple presence of microplastics in the colon is not, by itself, enough to explain colorectal cancer.
The most compelling epidemiological signal so far comes from a large study of microplastics in human feces. Researchers measured the particle load in stool from colorectal cancer patients and healthy controls and found that all samples contained microplastics, but colorectal cancer patients had higher levels on average. They also observed differences in the distribution of polymer types, with a higher proportion of polyethylene terephthalate and polyamide in the cancer group. Using statistical models, the authors reported that a higher microplastic load in feces was associated with increased colorectal cancer risk. They also identified factors such as female sex, frequent consumption of spicy food, and eating fast food more than twice per week as variables that further elevated risk in the context of microplastic exposure.
Animal studies provided another angle. In mouse models of colitis associated colorectal cancer, where tumors are already expected to form, exposure to microplastics led to higher tumor burdens compared to controls. Some of these models involved the established azoxymethane and dextran sulfate sodium protocol that induces chronic colon inflammation. Others used mice injected with colon cancer cells. Across these designs, microplastics exposure was consistently linked with more tumors and with changes to the gut microbiome, a pattern referred to as dysbiosis.

Interestingly, when healthy wildtype mice without induced colitis were exposed to microplastics, they did not spontaneously develop colorectal cancer or marked DNA damage in the colon. They did, however, show shortening of the gastrointestinal tract and subtle molecular changes. This contrast supports the idea that microplastics may act as accelerants or amplifiers of tumorigenesis when the intestinal barrier is already compromised rather than as stand alone causes of cancer in an otherwise healthy gut.
The review underscores that many people have disrupted gut barriers due to chronic inflammatory bowel disease, smoking, alcohol use, stress, infections, medications, or diets associated with Western eating patterns. In these contexts, microplastics and nanoplastics could potentially have a greater impact on colorectal cancer risk by exploiting existing weaknesses in the intestinal wall and immune defenses.
At the cellular level, in vitro experiments revealed several plausible mechanisms that could link microplastic exposure to colorectal cancer biology. Across multiple studies, colorectal cancer cell lines exposed to microplastics or nanoplastics showed increased production of reactive oxygen species. Elevated reactive oxygen species are known to damage DNA and promote the mutations and inflammatory signaling associated with cancer initiation, though very high levels can also kill cells. Some experiments observed clear DNA damage in exposed colon cells, and one group reproduced these effects in a mouse model of colitis.
There were also effects on cell survival and behavior. In some cell lines, low doses of microplastics promoted proliferation, invasion, and resistance to chemotherapy agents such as oxaliplatin. Researchers linked these effects to changes in autophagy and inhibition of pyroptosis, pathways that normally help regulate cell death. Experiments further suggested that microplastics disrupted lipid metabolism in colon cells, adding a metabolic layer to their potential role in tumorigenesis.
An intriguing detail from one study was that chemical leachates from weathered plastics could induce oxidative stress and DNA damage in colon cancer cells even in the absence of the physical particles. Different polymers had different effects. Nylon leachate increased reactive oxygen species and DNA damage, while extracts from polyvinyl chloride and high density polyethylene damaged DNA without detectable increases in reactive oxygen species. This points toward complex contributions from both the plastic matrix and its associated additives.
Despite these converging signals, the review is careful not to overstate the case. The current human data are correlational, based on limited sample sizes and populations that are not yet globally representative. Causality is far from proven. The experimental models frequently use microplastic types and sizes that do not perfectly mirror what is most abundant in human tissues and feces, and results can vary between studies. Ethical constraints also limit the possibility of controlled human exposure experiments, which means future progress will rely heavily on better observational studies and refined animal and cell models.
The authors argue that as this evidence base grows, it will be important to tighten research standards around microplastics. That includes clear reporting of polymer type, size distribution, source, purity, and potential contamination from laboratory materials. They suggest that standardized guidelines could improve comparability between studies, reduce conflicting results, and help regulators make informed decisions.
For now, the review concludes that microplastics and nanoplastics are present in the human colon, show up at higher levels in the feces of colorectal cancer patients, and can trigger biological changes associated with colorectal tumorigenesis, particularly in the context of a compromised intestinal barrier. While science is still unraveling the exact role of these particles in colorectal cancer, the available findings point toward toxic rather than benign effects. In light of this, the authors suggest that it may be prudent to begin reducing plastic use in food and beverage packaging where feasible, increase transparency about the types of plastics that come into contact with food, and support policies that limit plastic pollution and production so that microplastic and nanoplastic exposure can be curtailed over time.
Read more at https://pmc.ncbi.nlm.nih.gov/articles/PMC13427794/